These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9399969)

  • 1. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum.
    Yoshikawa T; Yoshida N; Mine Y; Hosoki K
    Jpn J Pharmacol; 1998 May; 77(1):53-9. PubMed ID: 9639060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-HT4 agonist mosapride enhances rectorectal and rectoanal reflexes in guinea pigs.
    Shimatani H; Kojima Y; Kadowaki M; Nakagawa T; Fujii H; Nakajima Y; Takaki M
    Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G389-95. PubMed ID: 12724131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mosapride citrate on proximal and distal colonic motor function in the guinea-pig in vitro.
    Kim HS; Choi EJ; Park H
    Neurogastroenterol Motil; 2008 Feb; 20(2):169-76. PubMed ID: 17931343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
    Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological effects of the gastroprokinetic agent mosapride citrate].
    Yoshida N
    Nihon Yakurigaku Zasshi; 1999 May; 113(5):299-307. PubMed ID: 10480157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs.
    Inui A; Yoshikawa T; Nagai R; Yoshida N; Ito T
    Jpn J Pharmacol; 2002 Dec; 90(4):313-20. PubMed ID: 12501007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into the effects of mosapride on motility of Guinea pig stomach, ileum, and colon.
    Ji SW; Park HJ; Cho JS; Lim JH; Lee SI
    Yonsei Med J; 2003 Aug; 44(4):653-64. PubMed ID: 12950122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo.
    Tsubouchi T; Saito T; Mizutani F; Yamauchi T; Iwanaga Y
    J Pharmacol Exp Ther; 2003 Aug; 306(2):787-93. PubMed ID: 12724347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.
    Yoshida N; Ito T; Karasawa T; Itoh Z
    J Pharmacol Exp Ther; 1991 May; 257(2):781-7. PubMed ID: 2033519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal and rectoanal reflexes after removal of extrinsic nerves in guinea pigs.
    Kojima Y; Nakagawa T; Katsui R; Fujii H; Nakajima Y; Takaki M
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G351-60. PubMed ID: 15817810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
    Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
    de Ridder WJ; Schuurkes JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized rat.
    Armstrong SR; McCullough JL; Beattie DT
    J Pharmacol Toxicol Methods; 2006; 53(3):198-205. PubMed ID: 16168678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats.
    Ataka K; Kuge T; Fujino K; Takahashi T; Fujimiya M
    Auton Neurosci; 2007 May; 133(2):136-45. PubMed ID: 17182287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
    Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
    Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation into the contractile response of melatonin in the guinea-pig isolated proximal colon: the role of 5-HT4 and melatonin receptors.
    Lucchelli A; Santagostino-Barbone MG; Tonini M
    Br J Pharmacol; 1997 Aug; 121(8):1775-81. PubMed ID: 9283717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic effect of a selective 5-HT4 receptor agonist.
    Nishikawa T; Tsuno NH; Shuno Y; Sasaki K; Hongo K; Okaji Y; Sunami E; Kitayama J; Takahashi K; Nagawa H
    J Surg Res; 2010 Apr; 159(2):696-704. PubMed ID: 19515383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.